NIH Announces Pediatric Seizure Study
The National Institute of Child Health and Human Development (NICHD) has announced plans to conduct a large-scale study to determine which of the two most commonly-prescribed medications; diazepam (Valium) or lorazepam (Ativan), is the safer and more effective treatment for children with status epilepticus [more].
Recent Videos
Related Content
Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP
September 13th 2024Article
The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing the biologic.
